Variation in Potency and Spectrum of Tigecycline Activity against Bacterial Strains from U.S. Medical Centers since Its Approval for Clinical Use (2006 to 2012)

Helio S. Sader, David J. Farrell, Robert K. Flamm, Ronald N. Jones
  • Antimicrobial Agents and Chemotherapy, February 2014, ASM Journals
  • DOI: 10.1128/aac.02684-13
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Helio S Sader

In partnership with: